Markets市場

Grail shareholders face $51.32-per-share loss claim as Levi & Korsinsky targets NHS-Galleri confidence collapse

Confidence in early-detection diagnostics can reverse sharply, and one such reversal has now drawn formal legal action. Grail, Inc. (NASDAQ: GRAL) is at the center of a securities class action

By Vincent Lorne·July 19, 2026·二〇二六年七月十九日·2 min read